Blood cancer drug safety tracked in Long-Term study
NCT ID NCT06876649
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the long-term safety of the drug pirtobrutinib in people with chronic lymphocytic leukemia or non-Hodgkin lymphoma. About 787 participants who completed an earlier pirtobrutinib study can join to keep receiving treatment or have follow-up visits. The main goal is to track serious side effects and overall survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nantes - Hotel Dieu
RECRUITINGNantes, 44093, France
-
Cancer Specialists, LLC
NOT_YET_RECRUITINGJacksonville, Florida, 32256, United States
-
Cayuga Cancer Center
RECRUITINGIthaca, New York, 14850, United States
-
Churchill Hospital
NOT_YET_RECRUITINGOxford, OX3 7LE, United Kingdom
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Derriford Hospital
RECRUITINGPlymouth, PL6 8DH, United Kingdom
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710-4000, United States
-
Flinders Medical Centre
RECRUITINGAdelaide, 5042, Australia
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232-6422, United States
-
Hokkaido University Hospital
RECRUITINGSapporo, 060-8648, Japan
-
IRCCS-AOU di Bologna-Policlinico S.Orsola-Malpighi
RECRUITINGBologna, 40138, Italy
-
Instytut Hermatologii I Transfuzjologii
RECRUITINGWarsaw, 02776, Poland
-
Linear Clinical Research
RECRUITINGVictoria, 3000, Australia
-
Mayo Clinic- Minnesota
RECRUITINGRochester, Minnesota, 55905, United States
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226-3548, United States
-
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York
RECRUITINGNew York, New York, 10065-6007, United States
-
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York
NOT_YET_RECRUITINGNew York, New York, 10065-6007, United States
-
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York
NOT_YET_RECRUITINGNew York, New York, 10065-6007, United States
-
Nagoya Medical Center
RECRUITINGAichi-Ken, 4600001, Japan
-
National Cancer Center Hospital
RECRUITINGCho-ku, 104-0045, Japan
-
National Hospital Organization Kyushu Cancer Center
RECRUITINGFukuoka, 811-1395, Japan
-
Northwell Health
RECRUITINGLake Success, New York, 11042-1118, United States
-
Northwestern University
NOT_YET_RECRUITINGChicago, Illinois, 60611-3013, United States
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210-1063, United States
-
Ospedale San Raffaele
RECRUITINGMilan, 20132, Italy
-
Peter MacCallum Cancer Centre
RECRUITINGMelbourne, 3000, Australia
-
Pratia MCM Krakow
RECRUITINGKrakow, 30727, Poland
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
St James's University Hospital
RECRUITINGLeeds, LS9 7TF, United Kingdom
-
Swedish Cancer Institute
RECRUITINGSeattle, Washington, 98104-3588, United States
-
Sylvester Comprehensive Cancer Center
RECRUITINGMiami, Florida, 33136-1002, United States
-
Tennessee Oncology
RECRUITINGNashville, Tennessee, 37203-2659, United States
-
The Emory Clinic
NOT_YET_RECRUITINGAtlanta, Georgia, 30322-1013, United States
-
Tohoku University Hospital
RECRUITINGMiyagi-Ken, 9808574, Japan
-
Tokai University Hospital- Isehara Campus
RECRUITINGIsehara, 259-1193, Japan
-
University Of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 69198, United States
-
University of Pennsylvania Hospital
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a simple blood test spot lymphoma earlier?
- What happens years after CAR-T therapy? a study aims to find out